Twist Bioscience insider plans sale of 1,133 shares

Twist Bioscience Corporation insider Paula Green filed to potentially sell 1,133 shares of common stock through Fidelity Brokerage Services LLC on August 3, 2026 on the NASDAQ market.

Rhea-AI Filing Summary

Twist Bioscience Corporation insider Paula Green filed to potentially sell 1,133 shares of common stock through Fidelity Brokerage Services LLC on August 3, 2026 on the NASDAQ market. These shares are tied to restricted stock vesting on July 31, 2026 as compensation from the issuer.

The filing also lists sales of common stock during the prior three months: 1,116 shares on May 4, 2026 for $63,778.06; 1,399 shares on May 21, 2026 for $74,505.99; 884 shares on June 8, 2026 for $61,742.27; 26,137 shares on June 15, 2026 for $2,134,485.95; and 291 shares on June 22, 2026 for $25,410.82.

Key Figures

Planned shares to be sold: 1,133 shares Planned sale value: $96,668.92 Restricted stock vesting date: 07/31/2026 +5 more

8 metrics

Planned shares to be sold 1,133 shares Common stock proposed for sale on August 3, 2026

Planned sale value $96,668.92 Aggregate value of 1,133 shares of common stock

Restricted stock vesting date 07/31/2026 Vesting date for compensation shares underlying the planned sale

Shares sold 05/04/2026 1,116 shares Common stock sold for $63,778.06

Shares sold 05/21/2026 1,399 shares Common stock sold for $74,505.99

Shares sold 06/08/2026 884 shares Common stock sold for $61,742.27

Shares sold 06/15/2026 26,137 shares Common stock sold for $2,134,485.95

Shares sold 06/22/2026 291 shares Common stock sold for $25,410.82

Key Terms

Form 144, restricted stock vesting, compensation

3 terms

Form 144 regulatory

"Filer Information | | | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

restricted stock vesting financial

"Common | 07/31/2026 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

compensation financial

"1133 | 07/31/2026 | Compensation"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Twist Bioscience (TWST) disclose in this Form 144 filing?

The filing shows Paula Green may sell 1,133 shares of TWST common stock through Fidelity on August 3, 2026, with the shares originating from restricted stock vesting on July 31, 2026 as compensation.

How many TWST shares is Paula Green planning to sell under this Form 144?

Paula Green indicates a potential sale of 1,133 shares of Twist Bioscience common stock, with an aggregate value of $96,668.92. The shares are to be sold on the NASDAQ through Fidelity Brokerage Services LLC.

What prior TWST stock sales by Paula Green are listed in the last three months?

The filing lists sales of 1,116 shares on May 4, 1,399 shares on May 21, 884 shares on June 8, 26,137 shares on June 15, and 291 shares on June 22, 2026, with each transaction showing its own dollar amount.

What is the aggregate value of the planned TWST share sale in this Form 144?

The Form 144 shows the 1,133 shares of Twist Bioscience common stock have an aggregate value of $96,668.92. This value applies to the securities proposed for sale on August 3, 2026 via NASDAQ.

How were the TWST shares in this Form 144 acquired by Paula Green?

The 1,133 shares covered by this filing are tied to restricted stock vesting dated July 31, 2026. The acquisition source is noted as the issuer, and the nature of acquisition is listed as compensation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/03/2026 - 03:54 PM Accepted by SEC EDGAR 08/03/2026 - 03:53 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001753672
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Twist Bioscience Corp
SEC File Number	001-38720
Address of Issuer	681 GATEWAY BLVD. SOUTH SAN FRANCISCO CALIFORNIA 94080
Phone	800-719-0671
Name of Person for Whose Account the Securities are To Be Sold	Green Paula
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	1133	96668.92	62271314	08/03/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/31/2026	Restricted Stock Vesting	Issuer			1133	07/31/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Paula Green 681 Gateway Blvd South San Francisco CA 94080	Common	05/04/2026	1116	63778.06
Paula Green 681 Gateway Blvd South San Francisco CA 94080	Common	05/21/2026	1399	74505.99
Paula Green 681 Gateway Blvd South San Francisco CA 94080	Common	06/08/2026	884	61742.27
Paula Green 681 Gateway Blvd South San Francisco CA 94080	Common	06/15/2026	26137	2134485.95
Paula Green 681 Gateway Blvd South San Francisco CA 94080	Common	06/22/2026	291	25410.82

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	08/03/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Emily Navaro, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Paula Green.
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)